GENE jumps 120% off COVID-19 risk test then enters a trading halt – Does YIG see potential?

Most investors have probably never heard of Genetic Technologies (NASDAQ: GENE) before the coronavirus. However, ever since they announced a possible COVID-19 risk test, investors could not get enough. That is until today’s trading halt prevented people from investing. The COVID-19 pump and dump theory is becoming painstakingly common as the virus rages on. A […]